Sei Investments CO Apellis Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 30,155 shares of APLS stock, worth $999,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,155

Previous 34,666 13.01%

Holding current value

$999,336

Previous $1.33 Million 34.61%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$28.84 - $41.15 $130,097 - $185,627	-4,511 Reduced 13.01%	30,155 $869,000
Q2 2024 Aug 13, 2024	SELL	$38.07 - $59.71 $197,887 - $310,372	-5,198 Reduced 13.04%	34,666 $1.33 Million
Q1 2024 May 07, 2024	BUY	$55.39 - $72.47 $804,872 - $1.05 Million	14,531 Added 57.36%	39,864 $2.34 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $272,607 - $475,778	-7,340 Reduced 22.47%	25,333 $1.52 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $772,456 - $2.91 Million	-32,662 Reduced 49.99%	32,673 $1.24 Million
Q2 2023 Aug 11, 2023	BUY	$76.68 - $93.31 $1.08 Million - $1.32 Million	14,140 Added 27.62%	65,335 $5.95 Million
Q1 2023 May 12, 2023	BUY	$46.59 - $66.96 $1.88 Million - $2.71 Million	40,399 Added 374.2%	51,195 $3.38 Million
Q4 2022 Feb 10, 2023	SELL	$43.24 - $61.04 $1.95 Million - $2.75 Million	-45,125 Reduced 80.69%	10,796 $558,000
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $2.5 Million - $3.9 Million	55,921 New	55,921 $3.82 Million
Q3 2021 Nov 12, 2021	SELL	$31.4 - $69.84 $617,763 - $1.37 Million	-19,674 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$40.9 - $64.9 $139,305 - $221,049	3,406 Added 20.94%	19,674 $1.24 Million
Q4 2020 Feb 08, 2021	BUY	$30.79 - $57.2 $500,891 - $930,529	16,268 New	16,268 $931,000
Q2 2020 Aug 11, 2020	SELL	$24.8 - $38.49 $193,068 - $299,644	-7,785 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$17.91 - $44.33 $139,429 - $345,109	7,785 New	7,785 $209,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Apellis Pharmaceuticals, Inc. Transaction History